Skip to main content
Clinical Trials/NCT02087514
NCT02087514
Completed
Not Applicable

Duration of Red Blood Cell Storage Prior to Transfusion and Non-Transferrin-Bound Iron

Columbia University1 site in 1 country60 target enrollmentFebruary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Iron, Blood Level Abnormal
Sponsor
Columbia University
Enrollment
60
Locations
1
Primary Endpoint
Non-transferrin-bound Iron Level (AUC)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study will determine the minimal duration of red blood cell (RBC) storage that leads to increases in circulating non-transferrin-bound iron in healthy human volunteers post-transfusion. The results from this study will help guide national guidelines for appropriate duration of RBC storage prior to transfusion, which is currently 6 weeks by Food and Drug Administration (FDA) criteria. The overall objective of this research is to improve the safety of refrigerated storage of red blood cells before transfusion.

Detailed Description

Recent studies suggest that older stored blood is associated with worse outcomes in certain hospitalized patients. Red cells may be stored in a refrigerator prior to transfusion for up to 42 days by current FDA standards. Refrigerator storage of red cells is associated with a storage lesion and the survival of transfused red cells decreases with increasing storage time, thus older blood is associated with an increased delivery of hemoglobin-iron to certain parts of the body. The investigators have preliminary data in mice and humans suggesting that delivery of a significant iron load from aged red cells leads to the production of a potentially toxic form of circulating iron called non-transferrin-bound iron. In this prospective study of healthy volunteers, each subject will be randomized to receive transfusion of one RBC unit after 1, 2, 3, 4, 5, or 6 weeks of storage. The primary outcome will be the 24 hr area under the curve (AUC) of the serum non-transferrin bound iron concentration calculated from samples collected at 0, 2, 4, 6, 8, 10, 12, 14 and 24 hours after transfusion.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
February 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Steven L. Spitalnik

Professor of Pathology and Cell Biology

Columbia University

Eligibility Criteria

Inclusion Criteria

  • 18-65 years old
  • Body weight \>110 lbs
  • Hemoglobin \>12.5 g/dL

Exclusion Criteria

  • Ineligible for donation based on the New York Blood Center blood donor questionnaire
  • Systolic blood pressure \>180 or \<90 mm Hg, diastolic blood pressure \>100 or \<50 mm Hg
  • Heart rate \<50 or \>100
  • Temperature \>99.5 F prior to donation
  • Temperature \>100.4 F or subjective feeling of illness prior to transfusion (this is to avoid having a concurrent illness affect post-transfusion measurements);
  • Positive results on standard blood donor infectious disease testing
  • Positive urine pregnancy test

Outcomes

Primary Outcomes

Non-transferrin-bound Iron Level (AUC)

Time Frame: 0, 2, 4, 6, 8, 10, 12, 14 and 24 after transfusion

Area under the curve of change of Non-transferrin-bound iron from immediately after transfusion to end of observation (i.e., from 0-hr after transfusion to 24-hr after transfusion).

Study Sites (1)

Loading locations...

Similar Trials